| Authors: |
Gingras I; Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada., Holmes E; Frontier Science (Scotland) Ltd., Kincraig, UK., De Azambuja E; Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Nguyen DH; Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada., Izquierdo M; Novartis Pharma AG, Basel, Switzerland., Anne Zujewski J; National Cancer Institute, Bethesda, MD, USA., Inbar M; Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Naume B; Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Tomasello G; Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy., Gralow JR; Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA., Wolff AC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Harris L; Case Western Reserve University, Cleveland, OH, USA., Gnant M; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Moreno-Aspitia A; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA., Piccart MJ; Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Azim HA Jr; Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. |
